Plantify Foods Secures New Retail Chain to Sell Its Plant-Based Clean Label Products
Neve Yarak, Israel, March 04, 2024 (GLOBE NEWSWIRE) — Save Foods, Inc. (NASDAQ: SVFD) (FSE:80W) (“Save Foods”), a pioneer Agri-Food […]
Goliath’s Updated Model Confirms Six New Gold Veins for a Total of 10 Demonstrates Increased Tonnage Potential at Surebet Discovery on Golddigger Property, Golden Triangle, British Columbia
HIGHLIGHTS: Generation of the updated structural vein/shear Leap Frog model takes into consideration all the surface and drill data collected […]
The Joint Corp. to Participate in the 36th Annual Roth Conference
SCOTTSDALE, Ariz., March 04, 2024 (GLOBE NEWSWIRE) — The Joint Corp. (NASDAQ: JYNT), the nation’s largest provider of chiropractic care […]
Osisko Development Secures US$50 Million Funding to Commence Underground Development at Cariboo Gold Project
MONTREAL, March 04, 2024 (GLOBE NEWSWIRE) — Osisko Development Corp. (NYSE: ODV, TSXV: ODV) (“Osisko Development” or the “Company“) is […]
Ethisphere names Avista as one of the 2024 World’s Most Ethical Companies® for the fifth time
SPOKANE, Wash., March 04, 2024 (GLOBE NEWSWIRE) — Avista Corp. (NYSE: AVA), a Washington state-based energy company with operations spanning […]
Unicycive Therapeutics Announces Orphan Drug Designation Granted for UNI-494 by the U.S. Food and Drug Administration for the Prevention of Delayed Graft Function in Kidney Transplant Patients
LOS ALTOS, Calif., March 04, 2024 (GLOBE NEWSWIRE) — Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for […]
Rivalry to Present at SBC Summit Rio 2024
TORONTO, March 04, 2024 (GLOBE NEWSWIRE) — Rivalry Corp. (the “Company” or “Rivalry”) (TSXV: RVLY) (OTCQX: RVLCF) (FSE: 9VK), the […]
Passage Bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Recent Business Highlights
Continued momentum in upliFT-D trial of PBFT02 for the treatment of patients with frontotemporal dementia (FTD) with granulin mutations (GRN) […]
Arvinas to Participate in Upcoming Investor Conferences
NEW HAVEN, Conn., March 04, 2024 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new […]
ECARX’s Global Expansion Driven by Strong R&D and International Accreditations
SHANGHAI, China, March 04, 2024 (GLOBE NEWSWIRE) — ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility […]
